Salius Pharma Private Limited, a active private limited company, was established on 05 November 2011 in Thane, Maharashtra, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24233MH2011PTC223680. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.89 M.
It upholds a compliant status. Its leadership includes Rajdev Gulia (Director), Arati Patra (Director), Abani Kanta Patra (Director). Past directors included Harjeet Samra, Rupesh Kumar Gupta. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit 3104 To 3106, Plan S Business Park, D108/1,, Opp. D Y Patil Stadium, Midc Nerul, Navi Mumbai,, Thane, Maharashtra, 400706.
U24233MH2011PTC223680
223680
05 November 2011
₹1.00 Cr
₹9.89 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Salius Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajdev Gulia | Director | 18 Mar 2013 | Current |
| Arati Patra | Director | 17 Jan 2017 | Current |
| Abani Kanta Patra | Director | 05 Nov 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jun 2019 | Past |
| Pramod Abcsdd | Director | 15 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Salius Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.53% increase. The company also saw a substantial improvement in profitability, with a 98.91% increase in profit. The company's net worth Soared by an impressive increase of 10.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Salius Pharma had a public holding of 15.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2024 | Yes Bank Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Salius Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Salius Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salius Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Salius Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Yes Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100955870 was registered on 12 Jul 2024. was completed.
Salius Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Arati Patra was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Progress on Rajdev Gulia was appointed as a Director was appointed as a Director on 18 Mar 2013 & has been associated with this company since 12 years 8 months . was documented.
Abani Kanta Patra was appointed as a Director was appointed as a Director on 05 Nov 2011 & has been associated with this company since 14 years 26 days . was recorded as a recent event.
The CIN of Salius Pharma Private Limited is U24233MH2011PTC223680.
Salius Pharma Private Limited is headquartered at Unit 3104 To 3106, Plan S Business Park, D108/1,, Opp. D Y Patil Stadium, Midc Nerul, Navi Mumbai,, Thane, Maharashtra, 400706.
Salius Pharma Private Limited was incorporated on 05 November 2011.
The current directors of Salius Pharma Private Limited are
The primary industry of Salius Pharma Private Limited is Manufacturing.
Salius Pharma Private Limited is unlisted.
The authorized capital of Salius Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.89 M.
The compliance status of Salius Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX